Showing results (1-10 of 230) with videos related to
Sort By:
Pageof 23
Current Opinion in Oncology|September 9, 2024
Biomarker-directed therapy in multiple myelomaAdam Bryant, Hang QuachCancers|November 26, 2020
Shaping the Treatment Paradigm Based on the Current Understanding of the Pathobiology of Multiple Myeloma: An OverviewSlavisa Ninkovic, Hang QuachCancers|August 14, 2025
The Evolving Treatment Landscape for the Elderly Multiple Myeloma Patient: From Quad Regimens to T-Cell Engagers and CAR-TMatthew James Rees, Hang QuachHaematologica|November 4, 2005
Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximabHang Quach, Henry Januszewicz, David WestermanAmerican Journal of Hematology|May 30, 2012
Lenalidomide in multiple myeloma: Current status and future potentialHang Quach, Anna Kalff, Andrew SpencerHaematologica|December 24, 2025
Translocation t(11;14) and BCL2-inhibition in multiple myelomaShirlene Sim, Binod Dhakal, Hang QuachJournal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|May 28, 2011
Reversal of transfusion dependence by tumor necrosis factor inhibitor treatment in a patient with concurrent rheumatoid arthritis and primary myelofibrosisAnderson Ong, Hang Quach, Michelle LeechExpert Review of Hematology|September 29, 2020
Glucose-regulated protein 78 (GRP78) as a potential novel biomarker and therapeutic target in multiple myelomaSlavisa Ninkovic, Simon J Harrison, Hang QuachExpert Review of Hematology|June 15, 2011
Managing multiple myeloma in the elderly: are we making progress?Hang Quach, H Miles Prince, Andrew SpencerClinical Lymphoma, Myeloma & Leukemia|August 4, 2020
Perspectives in the Rapidly Evolving Treatment Landscape of Multiple Myeloma: Expert Review of New Data Presentations from ASH 2019Chng Wee Joo, Hang Quach, Noopur RajePageof 23